Crohn’s disease is diagnosed through a combination of blood tests, stool samples, imaging, and endoscopy with biopsies. No single test confirms it on its own. Instead, gastroenterologists piece together evidence from several sources to build a diagnosis, rule out infections or other conditions, and determine where in your digestive tract the disease is active.
Stool and Blood Tests Come First
The diagnostic process typically starts with noninvasive tests. A stool sample measuring a protein called fecal calprotectin is one of the most useful early screening tools. Your intestinal lining releases this protein when it’s inflamed. A level below 50 micrograms per gram is normal and suggests inflammation isn’t the problem. Between 50 and 120 is borderline, possibly reflecting mild inflammation. Above 120 strongly suggests active inflammation in the gut and usually triggers further investigation. The latest American College of Gastroenterology guidelines formally endorse a cutoff of 50 to 100 as the threshold for distinguishing inflammatory from non-inflammatory disease.
Blood tests check for anemia, elevated inflammatory markers (like C-reactive protein and sedimentation rate), and nutritional deficiencies that often accompany Crohn’s. These results don’t diagnose Crohn’s directly, but they help your doctor gauge how much inflammation is happening and how it’s affecting your body.
There are also antibody blood tests that can help differentiate Crohn’s from ulcerative colitis when the picture is unclear. One antibody pattern, called ASCA, is highly specific for Crohn’s, reaching 95% specificity for either the IgA or IgG type and 100% when both are positive. A different pattern, called pANCA, is 92% specific for ulcerative colitis. These tests aren’t used to diagnose Crohn’s in isolation, but they can tip the balance when a gastroenterologist is trying to distinguish between the two types of inflammatory bowel disease.
Colonoscopy: The Central Diagnostic Step
A colonoscopy with biopsies is the cornerstone of Crohn’s diagnosis. During the procedure, a gastroenterologist threads a flexible camera through your colon and, ideally, into the last section of your small intestine (the terminal ileum), which is one of the most common sites for Crohn’s inflammation.
Several visual patterns strongly suggest Crohn’s rather than other conditions. The inflammation tends to be patchy and discontinuous, with inflamed areas surrounded by stretches of normal-looking tissue. These are called skip lesions. In early disease, the doctor may see small, shallow erosions that can deepen into larger ulcers over time. In more advanced cases, swelling beneath the mucosal surface creates a bumpy, irregular texture described as cobblestoning. Unlike ulcerative colitis, which starts at the rectum and extends in a continuous pattern, Crohn’s can appear anywhere in the digestive tract and skips around unpredictably.
During the colonoscopy, the doctor takes small tissue samples (biopsies) from both inflamed and normal-looking areas. Under a microscope, pathologists look for features characteristic of Crohn’s. The most telling finding is a type of cell cluster called a non-caseating granuloma, but these only appear in about 50% of patients, so their absence doesn’t rule Crohn’s out. Another hallmark is transmural inflammation, meaning the inflammation extends through the full thickness of the bowel wall rather than staying confined to the inner lining. However, standard biopsies only sample the surface layers, so determining the full depth of inflammation sometimes requires clinical context or, in surgical cases, examination of a resected piece of bowel.
Imaging the Small Bowel
Because Crohn’s frequently affects parts of the small intestine that a colonoscope can’t reach, imaging plays a critical role. The two main options are MR enterography (an MRI-based technique) and CT enterography, both performed after you drink a contrast solution that distends the small bowel for clearer pictures.
Head-to-head comparisons show similar performance: MR enterography detects active small-bowel Crohn’s with about 90.5% sensitivity, while CT enterography catches it about 95.2% of the time. CT enterography has somewhat better specificity (88.9% versus 66.7%), meaning it’s less likely to flag something as Crohn’s when it isn’t. In practice, MR enterography is often preferred for younger patients and for repeat imaging over time because it doesn’t use radiation. CT enterography may be chosen when speed matters or MRI isn’t available.
The updated ACG guidelines also formally endorse intestinal ultrasound as a radiation-free option for both initial diagnosis and ongoing monitoring. It’s particularly useful for checking bowel wall thickness and detecting complications, though its accuracy depends on the operator’s experience.
Capsule Endoscopy for Hard-to-Reach Areas
When colonoscopy and standard imaging leave questions unanswered, capsule endoscopy can fill the gap. You swallow a pill-sized camera that takes thousands of images as it travels through your digestive tract. It’s especially useful for evaluating the middle portions of the small bowel, for post-surgical patients whose anatomy makes colonoscopy difficult, and for cases where symptoms, anemia, or elevated biomarkers persist despite a normal colonoscopy.
The main limitation is strictures. If Crohn’s has narrowed a section of your bowel, the capsule can get stuck. For this reason, if there’s any suspicion of a stricture or obstruction, doctors will either use cross-sectional imaging first or have you swallow a dissolvable “patency capsule” that confirms the camera can pass safely. In pediatric patients without strictures, capsule endoscopy tends to be particularly valuable, often leading to significant changes in treatment plans.
Telling Crohn’s Apart From Similar Conditions
Part of the diagnostic process is ruling out conditions that mimic Crohn’s. Infections (bacterial, viral, or parasitic) can cause similar symptoms and even similar-looking inflammation on colonoscopy, so stool cultures and pathogen testing are standard. Ulcerative colitis is the closest look-alike, but it follows a distinct pattern: continuous inflammation starting from the rectum, limited to the inner lining of the colon, and without granulomas on biopsy. Irritable bowel syndrome can cause overlapping symptoms like cramping and diarrhea but doesn’t produce the visible inflammation or elevated calprotectin levels seen in Crohn’s.
Certain medications, particularly anti-inflammatory painkillers, can also cause small-bowel ulcers that look like Crohn’s on imaging or capsule endoscopy. Your doctor will ask about medication use and may recommend stopping suspect drugs before repeating tests. Tuberculosis of the intestine is another consideration, especially in regions where TB is common, since it can produce granulomas that look similar under a microscope.
What the Process Looks Like in Practice
For most people, the path to diagnosis follows a predictable sequence. It starts with blood work and a stool calprotectin test, usually ordered by a primary care doctor or gastroenterologist after persistent symptoms like diarrhea, abdominal pain, weight loss, or blood in the stool. If those tests suggest inflammation, a colonoscopy with biopsies is scheduled. Depending on what the colonoscopy shows, imaging of the small bowel follows to map the full extent of disease.
The timeline varies. Some people receive a diagnosis within a few weeks if test results are clear-cut. Others, particularly those with mild or atypical symptoms, may go through several rounds of testing over months. On average, studies have found delays of several months to years between symptom onset and formal diagnosis, partly because early Crohn’s symptoms overlap with so many common conditions.
Once a diagnosis is confirmed, the same tools used for diagnosis become tools for monitoring. Calprotectin levels track inflammation over time without invasive procedures. Follow-up colonoscopies and imaging assess how well treatment is working and catch complications like strictures or fistulas early.